Fortress Biotech: Funding, Investors & Team (Sep 2026)
Fortress Biotech, Inc. is a biopharmaceutical company that has been recognized for its rapid growth in the technology, media, telecommunications, life sciences, and energy tech sectors. With a focus on acquiring, developing, and commercializing pharmaceutical products, Fortress has a diverse portfolio of both marketed and developmental drugs. They cover various areas such as oncology, rare diseases, and gene therapy. The company operates through a streamlined structure, enabling efficient drug development. Fortress has established partnerships with renowned research institutions and biopharmaceutical companies to maximize its opportunities, including Alexion Pharmaceuticals, AstraZeneca, and UK Hope, among others.
Fortress Biotech has raised $23.9M across 2 funding rounds on record, the most recent an undisclosed round of $10.0M announced in Nov 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Fortress Biotech Company Profile and Key Stats
Latest funding round on record: Nov 2023.
Fortress Biotech Funding Rounds
Fortress Biotech raised $13.9M in an undisclosed round announced in Feb 2023.
9 months later, an undisclosed round of $10.0M was announced in Nov 2023.
Fortress Biotech Founders and Leadership Team
No contact details are on record for this team yet.
Fortress Biotech Funding Compared to Other Biotechnology Startups
Fortress Biotech's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Fortress Biotech in Biotechnology and New York
Companies Similar to Fortress Biotech
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Fortress Biotech Funding FAQs
What does Fortress Biotech do?
Fortress Biotech, Inc. is a biopharmaceutical company that has been recognized for its rapid growth in the technology, media, telecommunications, life sciences, and energy tech sectors. With a focus on acquiring, developing, and commercializing pharmaceutical products, Fortress has a diverse portfolio of both marketed and developmental drugs. They cover various areas such as oncology, rare diseases, and gene therapy. The company operates through a streamlined structure, enabling efficient drug development. Fortress has established partnerships with renowned research institutions and biopharmaceutical companies to maximize its opportunities, including Alexion Pharmaceuticals, AstraZeneca, and UK Hope, among others.
How much funding has Fortress Biotech raised?
Fortress Biotech has raised $23.9M across 2 rounds on record. The most recent is an undisclosed round of $10.0M announced in Nov 2023.
When did Fortress Biotech last raise funding?
Fortress Biotech's most recent funding round on record is an undisclosed round of $10.0M, announced in Nov 2023.
Who founded Fortress Biotech?
FundedIQ lists Josh Rosenwald (Founder) at Fortress Biotech.
Who is the CEO of Fortress Biotech?
Lindsay Rosenwald is listed as CEO at Fortress Biotech.
Where is Fortress Biotech headquartered?
Fortress Biotech is based in New York, United States.
How many employees does Fortress Biotech have?
Fortress Biotech is in the 51-100 employee band.
How does Fortress Biotech's funding compare to other Biotechnology startups?
Fortress Biotech's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Fortress Biotech Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fortress Biotech is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.